Syntara Q1 2025 slides: Promising myelofibrosis data, strong $18M cash position
Syntara Q1 2025 slides: Promising myelofibrosis data, strong $18M cash position Source link
Syntara Q1 2025 slides: Promising myelofibrosis data, strong $18M cash position Source link
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Kadant, Inc. (NYSE:KAI) Q1 2025 Earnings Conference Call April 30, 2025 11:00 AM ET Company Participants Michael McKenney – Executive
What’s your favorite Trader Joe’s snack? If you’re a Trader Joe’s shopper, you probably have one. And there’s a good
Meta Platforms joined artificial intelligence Goliath Microsoft in reporting better-than-expected quarterly earnings results after the closing bell on April 30.
Microsoft (MSFT) reported fiscal third-quarter revenue and profits that surpassed analysts’ expectations, sending shares higher in extended trading Wednesday. The
Explore the exciting world of Sun Communities (NYSE: SUI) with our expert analysts in this Motley Fool Scoreboard episode. Check
Wednesday was one of the rare good days for the beleaguered marijuana industry, with stocks in the sector experiencing significant
Qualcomm CEO Cristiano Amon responds to a question during a keynote conversation at CES 2024, an annual consumer electronics trade
NEW YORK (AP) — Consumers can expect higher prices and delivery delays when the Trump administration ends a duty-free exemption